Literature DB >> 23564212

Old drug ifenprodil, new hope for PTSD with a history of childhood abuse.

Kenji Hashimoto, Tsuyoshi Sasaki, Akira Kishimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23564212     DOI： 10.1007/s00213-013-3092-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  11 in total

Review 1.  Sexual abuse and lifetime diagnosis of psychiatric disorders: systematic review and meta-analysis.

Authors:  Laura P Chen; M Hassan Murad; Molly L Paras; Kristina M Colbenson; Amelia L Sattler; Erin N Goranson; Mohamed B Elamin; Richard J Seime; Gen Shinozaki; Larry J Prokop; Ali Zirakzadeh
Journal:  Mayo Clin Proc       Date:  2010-05-10       Impact factor: 7.616

2.  Ifenprodil for the treatment of flashbacks in female posttraumatic stress disorder patients with a history of childhood sexual abuse.

Authors:  Akira Kishimoto; Motonori Kaneko; Yurie Gotoh; Kenji Hashimoto
Journal:  Biol Psychiatry       Date:  2011-11-08       Impact factor: 13.382

3.  Ifenprodil for the treatment of flashbacks in adolescent female posttraumatic stress disorder patients with a history of abuse.

Authors:  Tsuyoshi Sasaki; Kenji Hashimoto; Keiko Okawada; Junko Tone; Akira Machizawa; Aya Tano; Michiko Nakazato; Masaomi Iyo
Journal:  Psychother Psychosom       Date:  2013-08-09       Impact factor: 17.659

4.  Further characterization of [3H]ifenprodil binding to sigma receptors in rat brain.

Authors:  K Hashimoto; E D London
Journal:  Eur J Pharmacol       Date:  1993-05-12       Impact factor: 4.432

Review 5.  Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation.

Authors:  R A Chambers; J D Bremner; B Moghaddam; S M Southwick; D S Charney; J H Krystal
Journal:  Semin Clin Neuropsychiatry       Date:  1999-10

6.  Inhibition of G protein-activated inwardly rectifying K+ channels by ifenprodil.

Authors:  Toru Kobayashi; Kazuo Washiyama; Kazutaka Ikeda
Journal:  Neuropsychopharmacology       Date:  2006-03       Impact factor: 7.853

Review 7.  Glutamate receptors in extinction and extinction-based therapies for psychiatric illness.

Authors:  Karyn M Myers; William A Carlezon; Michael Davis
Journal:  Neuropsychopharmacology       Date:  2010-07-14       Impact factor: 7.853

8.  Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival.

Authors:  Teruo Hayashi; Tsung-Ping Su
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

9.  Tracing the flow of knowledge: geographic variability in the diffusion of prazosin use for the treatment of posttraumatic stress disorder nationally in the Department of Veterans Affairs.

Authors:  Ilan Harpaz-Rotem; Robert A Rosenheck
Journal:  Arch Gen Psychiatry       Date:  2009-04

10.  Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptors.

Authors:  Tamaki Ishima; Kenji Hashimoto
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240
View more
  3 in total

1.  Glutamatergic system abnormalities in posttraumatic stress disorder.

Authors:  Daisuke Nishi; Kenji Hashimoto; Hiroko Noguchi; Kei Hamazaki; Tomohito Hamazaki; Yutaka Matsuoka
Journal:  Psychopharmacology (Berl)       Date:  2015-08-22       Impact factor: 4.530

2.  Ifenprodil Improves Long-Term Neurologic Deficits Through Antagonizing Glutamate-Induced Excitotoxicity After Experimental Subarachnoid Hemorrhage.

Authors:  Jing-Yi Sun; Shi-Jun Zhao; Hong-Bin Wang; Ya-Jun Hou; Qiong-Jie Mi; Ming-Feng Yang; Hui Yuan; Qing-Bin Ni; Bao-Liang Sun; Zong-Yong Zhang
Journal:  Transl Stroke Res       Date:  2021-03-12       Impact factor: 6.829

Review 3.  Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor.

Authors:  Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-01-05       Impact factor: 5.270
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.